SUBSCRIBE
SUBSCRIBE

GSK Bio

NEWS
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Big Meetings This Week with GlaxoSmithKline, Roche, Sanofi Have Investors on Pins and Needles
November 2, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Prominent Fund Manager Urges GlaxoSmithKline to Break Up
October 26, 2015
 · 
2 min read
FRENZY: The Life Science M&A in 2015 Compared to 2005
Biotech Bay
FRENZY: The Life Science M&A in 2015 Compared to 2005
October 26, 2015
 · 
12 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Novartis AG and Roche Executives Continue to Deny Merger Ambitions
October 12, 2015
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
30-Year-Old Hedge-Fund Whiz Kid’s Axovant Starts Alzheimer’s Phase III Trial
October 6, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
GlaxoSmithKline Slaps “For Sale” Sign on Huge Pittsburgh Campus
October 2, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Job Trends
Cambridge’s bluebird bio Will Move to Huge Kendall Square Space Next Year
September 30, 2015
 · 
3 min read
Crowds Flock to Talent Connect in DC As Life Science Employers Seek New Workers
Job Trends
Crowds Flock to ‘Talent Connect’ in DC as Life Science Employers Seek New Workers
September 30, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Job Trends
GlaxoSmithKline to Shutter R&D Site in France and Shift Work to UK and US
September 25, 2015
 · 
2 min read
Load More
  • 2026 - Best Places to Work - Badge (1).png
JOBS
IN THE PRESS
Press Releases
Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee
May 28, 2025
 · 
9 min read
Press Releases
Vesalius Announces Multi-Target Strategic Alliance with GSK to Develop Breakthrough Treatments for People Afflicted with Parkinson’s Disease
November 12, 2024
 · 
4 min read
Press Releases
Expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine approved in Canada for adults aged 50-59 at increased risk
November 5, 2024
 · 
7 min read
Press Releases
GSK Presents Positive Data for AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Indicating Protection Over Three RSV Seasons
October 8, 2024
 · 
10 min read
Pharm Country
GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise
March 7, 2024
 · 
5 min read
Pharm Country
GSK Announces AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Is Now Available at All Major US Retail Pharmacies
August 17, 2023
 · 
6 min read
Deals
BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition
May 16, 2023
 · 
7 min read
Business
AnaptysBio- and GSK-partnered immuno-oncology agent JEMPERLI (dostarlimab-gxly) meets primary endpoint in Phase 3 RUBY trial in primary advanced or recurrent endometrial cancer
December 2, 2022
 · 
5 min read